Literature DB >> 26607190

Use of ticagrelor in human pregnancy, the first experience.

Marjan Verbruggen1, Dominique Mannaerts1, Joke Muys1, Yves Jacquemyn1.   

Abstract

Ticagrelor was daily administered throughout pregnancy to a 37-year-old pregnant woman until 36 weeks of gestation. The patient, with Behçet disease, suffered from a non-ST elevation myocardial infarction 4 months before conception, possibly related to hypertension and tobacco abuse. Pregnancy and postpartum periods were uneventful. She delivered a healthy but small-for-gestational-age term neonate. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26607190      PMCID: PMC4680596          DOI: 10.1136/bcr-2015-212217

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

Review 1.  Successful gestation and delivery using clopidogrel for secondary stroke prophylaxis: a case report and literature review.

Authors:  Christopher R Reilly; Ana Cuesta-Fernandez; Omar R Kayaleh
Journal:  Arch Gynecol Obstet       Date:  2014-05-06       Impact factor: 2.344

Review 2.  Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non-ST-Elevation Acute Coronary Syndrome.

Authors:  Chirag Bavishi; Sadik Panwar; Franz H Messerli; Sripal Bangalore
Journal:  Am J Cardiol       Date:  2015-06-04       Impact factor: 2.778

Review 3.  The future of P2Y12 receptor antagonists.

Authors:  Mark R Thomas; Robert F Storey
Journal:  Platelets       Date:  2015-06-04       Impact factor: 3.862

  3 in total
  2 in total

1.  Preeclampsia-Associated Multivessel Spontaneous Coronary Artery Dissection.

Authors:  Rajeev Virender Seecheran; Jessica Kawall; Divya Ramadhin; Valmiki Krishna Seecheran; Sangeeta Anjali Persad; Sasha Savitri Lalla; Naveen Anand Seecheran
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

Review 2.  Neurocritical Care of the Pregnant Patient.

Authors:  Deepa Malaiyandi; Elysia James; Lindsay Peglar; Nurose Karim; Nicholas Henkel; Kristin Guilliams
Journal:  Curr Treat Options Neurol       Date:  2021-06-21       Impact factor: 3.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.